Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (321-330 of 421) with videos related to

Pageof 43
Sort By:
Journal of Thrombosis and Thrombolysis|November 6, 2023
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registryPaolo Prandoni, Sylvia Haas, Meg E Fluharty, et al.
Thrombosis Research|February 1, 2017
Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trialAlok A Khorana, Charles W Francis, Nicole M Kuderer, et al.
Plos One|February 12, 2020
Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysisNoémie Kraaijpoel, Marc Carrier, Grégoire Le Gal, et al.
Kidney International Reports|April 30, 2025
Erratum to "Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome" [<i>Kidney International Reports</i> Volume 9, Issue 10, October 2024, Pages 3053-3056]David Massicotte-Azarniouch, Daniel J Crona, Priscilla Karnabi, et al.
Kidney International Reports|October 21, 2024
Anticoagulation for the Prevention of Thrombotic Events in Nephrotic SyndromeDavid Massicotte Azarniouch, Daniel J Crona, Priscilla Karnabi, et al.
Journal of Thrombosis and Haemostasis : JTH|October 23, 2024
Impact of limited language proficiency on participation in venous thromboembolism research: a retrospective analysisDesmond Anuku, Marc Carrier, Grégoire Le Gal, et al.
Critical Care Medicine|October 12, 2021
Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-AnalysisAlexandre Tran, Shannon M Fernando, Bram Rochwerg, et al.
American Journal of Hematology|May 31, 2022
Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populationsWilson L da Costa, Danielle Guffey, Abiodun Oluyomi, et al.
American Journal of Hematology|November 10, 2025
A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe StudyTzu-Fei Wang, Erik Yeo, Peter L Gross, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 16, 2023
Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US ProgramKimberly Snow Caroti, Alok A Khorana, Cecilia Becattini, et al.
Pageof 43

Showing results (321-330 of 421) with videos related to

Sort By:
Pageof 43
Journal of Thrombosis and Thrombolysis|November 6, 2023
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registryPaolo Prandoni, Sylvia Haas, Meg E Fluharty, et al.
Thrombosis Research|February 1, 2017
Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trialAlok A Khorana, Charles W Francis, Nicole M Kuderer, et al.
Plos One|February 12, 2020
Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysisNoémie Kraaijpoel, Marc Carrier, Grégoire Le Gal, et al.
Kidney International Reports|April 30, 2025
Erratum to "Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome" [<i>Kidney International Reports</i> Volume 9, Issue 10, October 2024, Pages 3053-3056]David Massicotte-Azarniouch, Daniel J Crona, Priscilla Karnabi, et al.
Kidney International Reports|October 21, 2024
Anticoagulation for the Prevention of Thrombotic Events in Nephrotic SyndromeDavid Massicotte Azarniouch, Daniel J Crona, Priscilla Karnabi, et al.
Journal of Thrombosis and Haemostasis : JTH|October 23, 2024
Impact of limited language proficiency on participation in venous thromboembolism research: a retrospective analysisDesmond Anuku, Marc Carrier, Grégoire Le Gal, et al.
Critical Care Medicine|October 12, 2021
Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-AnalysisAlexandre Tran, Shannon M Fernando, Bram Rochwerg, et al.
American Journal of Hematology|May 31, 2022
Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populationsWilson L da Costa, Danielle Guffey, Abiodun Oluyomi, et al.
American Journal of Hematology|November 10, 2025
A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe StudyTzu-Fei Wang, Erik Yeo, Peter L Gross, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 16, 2023
Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US ProgramKimberly Snow Caroti, Alok A Khorana, Cecilia Becattini, et al.
Pageof 43